Equillium, Inc. - Common Stock (NQ:EQ)

1.415 -0.025 (-1.74%)

Delayed Quote Updated: 11:59 AM EDT, Oct 9, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Equillium, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >

Equillium Reports Third Quarter 2022 Financial Results and Provides Corporate and Clinical Updates

November 14, 2022

From Equillium, Inc.

Via Business Wire

Equillium Announces Data Suggesting Soluble ALCAM as a Potential Biomarker of Disease Severity in Lupus Nephritis at ACR Convergence 2022

November 14, 2022

From Equillium, Inc.

Via Business Wire

Equillium Announces Initiation of Phase 2 study of EQ101 A First-in-Class Multi-Cytokine Inhibitor of IL-2, IL-9 and IL-15 Targeting Alopecia Areata

November 10, 2022

From Equillium, Inc.

Via Business Wire

Equillium Shares Ride Higher After Positive Data From Lead Asset In Kidney Inflammation ↗

September 27, 2022

Via Benzinga

Equillium Buys Inflammatory Bowel Disease Player In All-Stock Deal ↗

September 07, 2022

Via Benzinga

Equillium to Present at Two Upcoming Investor Conferences

November 08, 2022

From Equillium, Inc.

Via Business Wire

Equillium Announces Presentation at the 6th Annual Dermatology Drug Development Summit

November 03, 2022

From Equillium, Inc.

Via Business Wire

Equillium Announces Initiation of Phase 1 study of EQ102, A First-in-Class Multi-Cytokine Inhibitor of IL-15 and IL-21 Targeting Celiac Disease

November 02, 2022

From Equillium, Inc.

Via Business Wire

Equillium Announces Presentation of Data Demonstrating Biological Importance of Multi-Cytokine Inhibitors EQ101 and EQ102 at the La Jolla Immunology Conference

October 26, 2022

From Equillium, Inc.

Via Business Wire

Why NLS Pharmaceutics Shares Dipped Over 23%; Here Are 67 Biggest Movers From Yesterday ↗

September 28, 2022

Gainers

Via Benzinga

Why Is Equillium (EQ) Stock Soaring 20% Today? ↗

September 27, 2022

Biotech firm Equillium is on the move as it released positive data for a lupus therapeutic, though EQ stock has a tough road ahead.

Via InvestorPlace

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

September 27, 2022

Gainers

Via Benzinga

This Analyst Boosts PT On PepsiCo? Plus UBS Sees $75 For Micron Technology ↗

September 27, 2022

Deutsche Bank raised the price target on PepsiCo, Inc. (NASDAQ: PEP) from $179 to $181. Deutsche Bank analyst Steve Powers maintained a Hold rating on the stock. PepsiCo shares fell 1.2% to $166.47 on...

Via Benzinga

Why Bellerophon Therapeutics Shares Are Trading Higher By 24%, Here Are 44 Stocks Moving In Tuesday's Mid-Day Session ↗

September 27, 2022

Gainers

Via Benzinga

Here's Why Equillium Stock Is Skyrocketing ↗

September 27, 2022

Equillium Inc (NASDAQ: EQ) shares are trading higher by 23.32% to $2.38 Tuesday morning after the company reported interim results from the Type B portion of the EQUALISE study evaluating itolizumab....

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

September 27, 2022

Gainers 9 Meters Biopharma (NASDAQ:NMTR) stock moved upwards by 22.8% to $0.25 during Tuesday's pre-market session. The company's market cap stands at $65.8 million.

Via Benzinga

Equillium Announces Positive Interim Results from the EQUALISE Study in Subjects with Lupus Nephritis

September 27, 2022

From Equillium, Inc.

Via Business Wire

Equillium Announces Abstract Accepted for Presentation at ACR Convergence 2022

September 15, 2022

From Equillium, Inc.

Via Business Wire

EQ Stock Alert: Halper Sadeh LLP is Investigating Whether the Merger of Equillium, Inc. is Fair to Shareholders

September 06, 2022

From Halper Sadeh LLP

Via Business Wire

Equillium to Acquire Metacrine in All-Stock Transaction

September 06, 2022

From Equillium, Inc.

Via Business Wire

Equillium to Present at Two Upcoming Investor Conferences

August 31, 2022

From Equillium, Inc.

Via Business Wire

Equillium Reports Second Quarter 2022 Financial Results and Provides Clinical Development Updates

August 15, 2022

From Equillium, Inc.

Via Business Wire

Why CinCor Pharma Is Trading Higher By 63%, Here Are 79 Stocks Moving In Monday's Mid-Day Session ↗

August 08, 2022

Gainers Bonso Electronics International Inc. (NASDAQ: BNSO) shares jumped 132% to $11.12 after jumping around 46% on Friday. The company recently said it expects unaudited comprehensive loss of $1.6...

Via Benzinga

Equillium Announces Presentation at the 3rd Annual Cytokine-Based Drug Development Summit

July 28, 2022

From Equillium, Inc.

Via Business Wire

89 Biggest Movers From Friday ↗

June 21, 2022

Gainers Revlon, Inc. (NYSE: REV) jumped 91.3% to close at $3.73 on Friday after the company filed for Chapter 11 bankruptcy.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

June 15, 2022

Via Benzinga

Approval Of Baricitinib For Patchy Baldness Validates Clinical Patch For This Small-Cap Stock ↗

June 14, 2022

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

May 27, 2022

During Friday's session, 59 stocks hit new 52-week lows.

Via Benzinga

Equillium to Present at Two Upcoming Investor Conferences

May 17, 2022

From Equillium, Inc.

Via Business Wire

Equillium Reports First Quarter 2022 Financial Results and Provides Corporate and Clinical Development Updates

May 12, 2022

From Equillium, Inc.

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.